Pioglitazone
Makes the body more sensitive to insulin.
- Starts working
- Varies
- Half-life
- 3–7 hours (metabolites 16–24 hours)
- In use since
- 1999
- Pregnancy
- Usually avoided
Overview
Pioglitazone improves insulin sensitivity and also helps fatty liver inflammation. It causes fluid retention and weight gain, so it's avoided in heart failure, and is used less often since newer drugs arrived.
Conditions it's used for
How it works
Helps your muscles and fat respond to insulin.
Pioglitazone belongs to the Thiazolidinediones. How Thiazolidinediones work: switch on genes in fat and muscle that improve insulin sensitivity.
Uses
- Type 2 diabetes
- Fatty liver inflammation (MASH, off-label)
Available as: tablet, combination tablets.
Typical dose
- Adults
- 15–45 mg once a day.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Weight gain
- Fluid retention
- Headache
Serious — get medical help
Uncommon, but need prompt attention
- Heart failure
- Bone fractures
- Bladder cancer (small possible increase)
- Macular swelling
Warnings
- Not with heart failure or bladder cancer history
- Report blood in urine
Interactions
- Insulin — more fluid retention
- Gemfibrozil — levels rise
Pregnancy and breastfeeding
Usually avoided
Not recommended.
Breastfeeding advice can differ from pregnancy advice — check with a pharmacist, or the LactMed database.
Brand names
- United States
- Actos
- United Kingdom
- Actos
- India
- Pioz, Piosys
- Australia
- Actos
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Why do my ankles swell?
It makes the kidneys hold salt and water. Tell your doctor, especially if you get breathless.
Do I need a prescription for Pioglitazone?
Yes — Pioglitazone is prescription-only in most countries.
Can I take Pioglitazone during pregnancy?
Usually avoided. Not recommended. Always check with a doctor or midwife.
Related medicines
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — A10BG03
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.